Keywords and Phrases
N-acetylcysteine amide (NACA)
"Doxorubicin is a representative of the class of quinoid anthracycline antitumor drugs that are most widely used in cancer chemotherapy. Unfortunately, long-term treatment by doxorubicin is limited by cardiotoxicity due to generation of reactive oxygen species (ROS). This study was conducted to determine the effects of a new thiol antioxidant, N-acetylcysteine amide (NACA), on doxorubicin-induced cardiotoxicity. Our results suggest that doxorubicin (5/[mu]M) induces cardiotoxicity by increasing generation of ROS, decreasing levels of glutathione (GSH) and MTS, an important cell viability indicator, increasing malondialdehyde (MDA) levels and caspase-3 activity, decreasing activities of antioxidant enzymes, such as catalase, glutathione peroxidase and glutathione reductase and inducing apoptosis. NACA protected H9c2 cells from doxorubicin-induced cardiotoxicity, as evaluated by MTS assay. It also significantly reduced the generation of ROS and decreased MDA in doxorubicin-treated cells. In addition, NACA increased the GSH level, as well as the GSH/GSSG ratio, and the increased caspase-3 activity was significantly decreased by NACA. The activities of antioxidant enzymes were also reduced by NACA"--Abstract, page iii.
M.S. in Chemistry
University of Missouri--Rolla
ix, 61 pages
© 2006 Rong Shi, All rights reserved.
Thesis - Restricted Access
Library of Congress Subject Headings
Antineoplastic agents -- Toxicology
Print OCLC #
Electronic OCLC #
Link to Catalog Record
Electronic access to the full-text of this document is restricted to Missouri S&T users. Otherwise, request this publication directly from Missouri S&T Library or contact your local library.http://laurel.lso.missouri.edu/record=b5999603~S5
Shi, Rong, "Effects of a newly synthesized thiol antioxidant on doxorubicin-induced oxidative stress" (2006). Masters Theses. 5904.
Share My Thesis If you are the author of this work and would like to grant permission to make it openly accessible to all, please click the button above.